Physician profile
Christopher E Snyder
NPI 1003916974
$694.15
in general payments reported to CMS, 2019-2025
10 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $52.02 · 2021: $167 · 2022: $28.12 · 2023: $20.23 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $124.98 | 2025 | Ozempic |
| Ars Pharmaceuticals Operations, INC. | $124.96 | 2025 | Neffy |
| Janssen Pharmaceuticals, INC | $120.90 | 2021 | |
| Medtronic Vascular, INC. | $114.29 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $74.40 | 2021-2022 | |
| Amarin Pharma, INC. | $52.02 | 2020 | |
| Alkermes, INC. | $33.73 | 2025 | Lybalvi |
| Boston Scientific Corporation | $20.23 | 2023 | |
| Allergan, INC. | $15.62 | 2019 | |
| Pfizer INC. | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.